Note worthy news featured in this edition include:
Anna Chodos and Beatrice Mullington retire
Final requirements for HDAP submissions
Online Filing of Form 2 - Project Update
CPI-Based Price-Adjustment Factors for 2015
The Hearing Panel approved a VCU in the Teva Canada Innovation G.P-S.E.N.C. and the medicine Copaxone matter
New Publication - NPDUIS Research ... Read More
News & Events
23
May2014
23
May2014
The Institut national d’excellence en santé et en services sociaux (INESSS) has released its list of drugs under review for the October 2014 Liste de médicaments.
Comments from health professional groups and associations regarding these drugs can be sent to INESSS by May 30th, ... Read More
22
May2014
CDEC will review and provide recommendations on reimbursement of drugs for rare diseases (DRDs) according to an enhanced Common Drug Review approach, as per news released today in CDR Update- Issue 103.
CADTH incorporated suggestions from stakeholder feedback (invited in October ... Read More
20
Mar2014
Order Form
“Anytime you get something on the table that generates cost-savings, people perk up”
Public drug plan representative
“Patients want drug access—effective medicines to Canadians in a timely manner. The role of SEBs will be to provide Canadian patients a range of drugs at a range of ... Read More
20
Mar2014
Order Form
This special report (25 pages) provides an overview of the Canadian pharmaceutical pricing and reimbursement environment. It includes descriptions of the health care system and pharmaceutical market, and then discusses pharmaceutical pricing including the Patented ... Read More
20
Mar2014
2002 Update Now Available
Download the full 2002 report
Under a fully funded, publicly administered, national pharmacare program, government spending on prescribed drugs could increase by as much as $8.1 billion and would result in a dramatic shift in funding from the private sector to the public sector. The study, ... Read More
20
Mar2014
Abstract
OBJECTIVE. This paper compares the prices of top selling generic drugs in Canada with prices for comparable generic products in the United States.
METHODS. We examined the prices of 27 top selling (in 2001) generic prescription medicines in Canada that were marketed in both Canada and the United States. The sample ... Read More
20
Mar2014
Download the full report (66 Kb): Canada's Pharmaceutical Balance of Trade (PDF)
The purpose of this study is to develop an economic analysis of the Canadian balance of trade in pharmaceuticals. The study presents historical trends in pharmaceutical trade, makes comparisons with other high technology sectors, and outlines opportunities and ... Read More
20
Mar2014
Download the full report (100 Kb): C-91: Background Study on Drug Costs and Benefits (PDF)
This study examines the costs and benefits of pharmaceuticals in relation to the C-91 amendments to the Patent Act. The report is divided into two volumes. Volume 1 presents an analysis of the costs and ... Read More
18
Feb2014
Statistic Canada has released the final Consumer Price Index (CPI) figure for 2013 with full year annual inflation as measured by CPI increasing by 0.9% over 2012. For PMPRB price compliance, this is important for two reasons. First, this is the second year running ... Read More